Skip to main content
SpringerLink
Log in

Status Epilepticus in Older Patients

Epidemiology and Treatment Options

  • Review Article
  • Therapy in Practice
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Status epilepticus (SE) is a medical and neurological emergency that has been associated with significant morbidity and mortality. The most widely accepted definition of SE is more than 30 minutes of either continuous seizure activity, or intermittent seizures without full recovery of consciousness between seizures. SE is a major clinical concern in the elderly population, both because it has increased incidence in the elderly compared with the general population, and because of concurrent medical conditions that are more likely to complicate therapy and worsen prognosis in elderly individuals.

The incidence of SE in the elderly is almost twice that of the general population at 86 per 100 000 per year. With the anticipated growth of the elderly population, SE is likely to become an increasingly common problem facing clinicians, and an important public health issue. The elderly have the highest SE-associated mortality of any age group at 38%, and the very old elderly (>80 years of age) have a mortality of at least 50%. Acute or remote stroke is the most common aetiology of SE in the elderly. Nonconvulsive SE (NCSE) has a wide range of clinical presentations, ranging from confusion to obtundation. It occurs commonly in elderly patients who are critically ill and in the setting of coma. Electroencephalogram is the only reliable method of diagnosing NCSE.

The goal of treatment for SE is rapid cessation of clinical and electrical seizure activity. Most treatment protocols call for the immediate administration of an intravenous benzodiazepine, followed by phenytoin or fosphenytoin. Recent studies suggest that when this initial treatment of SE fails, little is gained by using additional standard drugs. General anaesthetic agents (such as pentobarbital, midazolam, or propofol) should be expeditiously employed, although these treatments have their own potential complications. Intravenous valproic acid is a recent addition to the armamentarium of drugs for the treatment of SE, with a low risk of hypotension, respiratory depression and hypotension, making it a potentially useful drug for the treatment of SE in the elderly. However, further information is needed to establish its role in the overall treatment of SE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I

Similar content being viewed by others

References

  1. DeLorenzo RJ, Pellock JM, Towne AR, et al. Epidemiology of status epilepticus. J Clin Neurophysiol 1995; 12(4): 316–25

    PubMed  CAS  Google Scholar 

  2. Towne AR, Pellock JM, Ko D, et al. Determinants of mortality in status epilepticus. Epilepsia 1994; 35(1): 27–34

    Article  PubMed  CAS  Google Scholar 

  3. Dodson WE, DeLorenzo RJ, Pedley TA, et al. The treatment of convulsive status epilepticus: recommendations of The Epilepsy Foundation of America’s Working Group on Status Epilepticus. JAMA 1993; 270: 854–9

    Article  Google Scholar 

  4. Lowenstein DH, Bleck T, Macdonald RL. It’s time to revise the definition of status epilepticus. Epilepsia 1999; 40(1): 120–2

    Article  PubMed  CAS  Google Scholar 

  5. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996; 46: 1029–35

    Article  PubMed  CAS  Google Scholar 

  6. DeLorenzo RJ. Clinical and epidemiologic study of status epilepticus in the elderly. In: Luders H, Noachtar S, editors. Epileptic seizures: pathophysiology and clinical semiology. Florida: Harcourt Brace & Company, 1997: 191–205

    Google Scholar 

  7. Hesdorffer DC, Logroscino G, Cascino G, et al. Incidence of status epilepticus in Rochester, Minnesota, 1965–1984. Neurology 1998; 50: 735–41

    Article  PubMed  CAS  Google Scholar 

  8. Sung CY, Chu NS. Status epilepticus in the elderly: etiology, seizure type and outcome. Acta Neurol Scand 1989; 80: 51–6

    Article  PubMed  CAS  Google Scholar 

  9. Celesia GG, Messert B, Murphy MJ. Status epilepticus of late adult onset. Neurology 1972; 22: 1047–55

    Article  PubMed  CAS  Google Scholar 

  10. Waterhouse EJ, Vaughan JK, Barnes TY, et al. Synergistic effect of status epilepticus and ischemic brain injury on mortality. Epilep Res 1998; 29: 175–83

    Article  CAS  Google Scholar 

  11. Labar D, Barrera J, Soloman G, et al. Nonconvulsive status epilepticus in the elderly: a case series and a review of the literature. J Epilepsy 1998; 11: 74–8

    Article  Google Scholar 

  12. Kaplan PW. Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurophysiol 1999; 16(4): 341–52

    Article  PubMed  CAS  Google Scholar 

  13. Lee SI. Nonconvulsive status epilepticus: ictal confusion in later life. Arch Neurol 1985; 42: 778–81

    Article  PubMed  CAS  Google Scholar 

  14. Privitera M, Hoffman M, Moore JL, et al. EEG detection of nontonic-clonic status epilepticus in patients with altered consciousness. Epilep Res 1994; 18: 155–66

    Article  CAS  Google Scholar 

  15. Towne AR, Waterhouse EJ, Boggs JG, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 2000; 54(2): 340–5

    Article  PubMed  CAS  Google Scholar 

  16. Drislane FW, Schomer DL: Clinical implications of generalized electrographic status epilepticus. Epilep Res 1994; 19: 111–21

    Article  CAS  Google Scholar 

  17. DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent non-convulsive status epilepticus following the control of convulsive status epilepticus. Epilepsia 1998; 39(8): 833–40

    Article  PubMed  CAS  Google Scholar 

  18. Litt B, Wityk RJ, Hertz SH, et al. Nonconvulsive status epilepticus in the critically ill elderly. Epilepsia 1998; 39(11): 1194–202

    Article  PubMed  CAS  Google Scholar 

  19. Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med 1998; 338(14): 970–6

    Article  PubMed  CAS  Google Scholar 

  20. Willmore LJ. Epilepsy emergencies: the first seizure and status epilepticus. Neurology 1998; 51Suppl. 4: S34–38

    Article  PubMed  CAS  Google Scholar 

  21. Leppik IE, Derivan AT, Homan RW, et al. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983; 249: 1452–4

    Article  PubMed  CAS  Google Scholar 

  22. Lowenstein DH, Alldredge BK, Gelb AM, et al. Results of a controlled trial of benzodiazepines for the treatment of status epilepticus in the prehospital setting [abstract]. Epilepsia 1999; 40Suppl. 7: 243

    Google Scholar 

  23. Wilder BJ. Efficacy of phenytoin in treatment of status epilepticus. In: Delgado-Escueta AV, Wasterlain CG, Treiman DM, et al., editors. Advances in neurology. Vol. 34. Status epilepticus: mechanisms of brain damage and treatment. New York: Raven Press, 1983: 441–6

    Google Scholar 

  24. Wilder BJ, Ramsay RE, Willmore LJ, et al. Efficacy of intravenous phenytoin in the treatment of status epilepticus. Ann Neurol 1977; 1: 511–8

    Article  PubMed  CAS  Google Scholar 

  25. Cranford RE, Leppik IE, Patrick B, et al. Intravenous phenytoin: clinical and pharmacokinetic aspects. Neurology 1978; 28: 874–80

    Article  PubMed  CAS  Google Scholar 

  26. Brown TR, Kugler AR, Eldon MA. Pharmacology and pharmacokinetics of fosphenytoin. Neurology 1996; 46Suppl. 1: S3–7

    Article  Google Scholar 

  27. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 1998; 339(12): 792–8

    Article  PubMed  CAS  Google Scholar 

  28. Treiman DM, Walton NY, Collins JF. Treatment of status epilepticus if first drug fails [abstract]. Epilepsia 1999; 40Suppl. 7: 243

    Google Scholar 

  29. Bleck TB: Management approaches to prolonged seizures and status epilepticus. Epilepsia 1999; Suppl. 1: S59–63

    Google Scholar 

  30. Lowenstein DH, Aminoff MJ, Simon RP. Barbiturate anesthesia in the treatment of status epilepticus. Neurology 1988; 38: 395–400

    Article  PubMed  CAS  Google Scholar 

  31. Krishnamurthy KB, Drislane FW. Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia 1996; 37(9): 863–7

    Article  PubMed  CAS  Google Scholar 

  32. Yaffe K, Lowenstein DH. Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus. Neurology 1993; 43(5): 895–900

    Article  PubMed  CAS  Google Scholar 

  33. Mirski MA, Williams MA, Hanley DF. Prolonged pentobarbital and phenobarbital coma for refractory generalized status epilepticus. Crit Care Med 1995; 23(2): 400–4

    Article  PubMed  CAS  Google Scholar 

  34. Stecker MM, Kramer TM, O’Meegham R, et al. Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia 1998; 39(1); 18–26

    Article  PubMed  CAS  Google Scholar 

  35. VanNess PC. Pentobarbital and EEG burst suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin. Epilepsia 1990; 31: 61–7

    Article  CAS  Google Scholar 

  36. Osorio I, Reed RC. Treatment of refractory generalized tonic-clonic status epilepticus with pentobarbital anesthesia after high dose phenytoin. Epilepsia 1989; 30: 464–71

    Article  PubMed  CAS  Google Scholar 

  37. Rashkin MC, Youngs C, Penovich P. Pentobarbital treatment of refractory status epilepticus. Neurology 1987; 37: 500–3

    Article  PubMed  CAS  Google Scholar 

  38. Kumar A, Bleck TP. Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med 1992; 20(4): 483–8

    Article  PubMed  CAS  Google Scholar 

  39. Parent JM, Lowenstein DH. Treatment of refractory generalized status epilepticus with continuous infusion of midazolam. Neurology 1994; 44: 1837–40

    Article  PubMed  CAS  Google Scholar 

  40. Denzel D, Burstein AH. Midazolam in refractory status epilepticus. Ann Pharmacother 1996; 30: 1481–3

    PubMed  CAS  Google Scholar 

  41. Kuisma M, Roine RO. Propofol in prehospital treatment of convulsive status epilepticus. Epilepsia 1995; 36(12): 1241–3

    Article  PubMed  CAS  Google Scholar 

  42. Venkataraman V, Wheless JW Safety of rapid intravenous infusion of valproate in epilepsy patients. Epilepsy Res 1999; 35(2): 147–53

    Article  PubMed  CAS  Google Scholar 

  43. Sinha S, Naritoku DK. Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology 2000; 55: 722–4

    Article  PubMed  CAS  Google Scholar 

  44. Giroud M, Gras D, Escousse A, et al. Use of injectable valproic acid in status epilepticus: a pilot study. Drug Invest 1993; 5(3): 154–9

    Article  Google Scholar 

  45. Price DJ. Intravenous valproate: experience in neurosurgery. In: Chadwick D, editor. Fourth International Symposium on Sodium Valproate and Epilepsy (International Congress and Symposium Series; No. 152). London: Royal Society of Medicine, 1989; 66: 348–54

    Google Scholar 

  46. Peters CNA, Pohlmann-Eden B. Efficacy and safety of intravenous valproate in status epilepticus [abstract]. Epilepsia 1999; 40Suppl. 7: 149

    Google Scholar 

  47. Knake S, Vescovi M, Hamer HH, et al. Intravenous sodium valproate in the treatment of status epilepticus [abstract]. Epilepsia 1999; 40Suppl. 7: 150

    Google Scholar 

  48. Short DW, Pack AM, Bazil CW. Depacon administration, safety, and efficacy in a hospital setting [abstract]. Epilepsia 1999; 40Suppl. 7: 226

    Google Scholar 

  49. Limdi NA, Faught E. Safety of rapid infusion of intravenous valproic acid infusion. Epilepsia 2000; 41(10): 1342–5

    Article  PubMed  CAS  Google Scholar 

  50. Pluhar JM, Birnbaum AK, Graves NM, et al. Valproic acid serum concentrations and daily dose in elderly nursing home residents: effects of age, gender, and concomitant medications [abstract]. Epilepsia 1999; 40Suppl. 7: 77

    Google Scholar 

  51. Kriel RL, Birnbaum AK, Norberg SK, et al. Pharmacokinetics of total and unbound valproate after rapid infusion of Depacon [abstract]. Epilepsia 1999; 40Suppl. 7: 232

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Medical College of Virginia of Virginia Commonwealth University, Richmond, Virginia, USA

    Elizabeth J. Waterhouse & Robert J. DeLorenzo

  2. Pharmacology and Toxicology, Medical College of Virginia of Virginia Commonwealth University, Richmond, Virginia, USA

    Robert J. DeLorenzo

  3. Biochemistry and Molecular Biophysics, Medical College of Virginia of Virginia Commonwealth University, Richmond, Virginia, USA

    Robert J. DeLorenzo

  4. Virginia Commonwealth University Comprehensive Epilepsy Institute, Medical College of Virginia of Virginia Commonwealth University, Richmond, Virginia, USA

    Elizabeth J. Waterhouse & Robert J. DeLorenzo

Authors
  1. Elizabeth J. Waterhouse
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert J. DeLorenzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elizabeth J. Waterhouse.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waterhouse, E.J., DeLorenzo, R.J. Status Epilepticus in Older Patients. Drugs & Aging 18, 133–142 (2001). https://doi.org/10.2165/00002512-200118020-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200118020-00006

Keywords

Search

Navigation